Premium
Letter: effectiveness of golimumab to induce remission in outpatient ulcerative colitis in Italy
Author(s) -
Tursi A.,
Della Valle N.,
Penna A.,
Pranzo G.,
Ricciardelli C.,
Picchio M.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13509
Subject(s) - golimumab , medicine , ulcerative colitis , clinical endpoint , adverse effect , infliximab , clinical trial , cohort , surgery , gastroenterology , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom